These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Biotech IPOs--flop or pop? Jacobs T Nat Biotechnol; 2004 Aug; 22(8):949. PubMed ID: 15286641 [No Abstract] [Full Text] [Related]
13. US venture capital for biotechnology. Dibner MD; Trull M; Howell M Nat Biotechnol; 2003 Jun; 21(6):613-7. PubMed ID: 12776144 [No Abstract] [Full Text] [Related]
14. Looking at US versus European exit opportunities. Lawrence S Nat Biotechnol; 2005 Oct; 23(10):1203. PubMed ID: 16302294 [No Abstract] [Full Text] [Related]
15. Mind the (biomedical funding) gap. Klausner A Nat Biotechnol; 2005 Oct; 23(10):1217-8. PubMed ID: 16211055 [No Abstract] [Full Text] [Related]
16. Chasing biotech, state by state--winners and losers. Wilan KH Nat Biotechnol; 2005 Feb; 23(2):175-9. PubMed ID: 15696143 [No Abstract] [Full Text] [Related]
17. Commercializing biotechnology in the UK. Searle S; Graves B; Towler C Nat Biotechnol; 2003 Jul; 21 Suppl():BE33-5. PubMed ID: 12874976 [No Abstract] [Full Text] [Related]
18. Divining the path to a successful European exit. Buch HK; Gustafsson AC; Drvota V; Sundberg CJ Nat Biotechnol; 2011 Mar; 29(3):205-7. PubMed ID: 21510008 [No Abstract] [Full Text] [Related]
19. Biotech holds its own in Q2. Lawrence S Nat Biotechnol; 2004 Aug; 22(8):938. PubMed ID: 15286634 [No Abstract] [Full Text] [Related]
20. The importance of angels in starting a US biotech venture. Sohl J Nat Biotechnol; 2005 Feb; 23(2):263-4. PubMed ID: 15724275 [No Abstract] [Full Text] [Related] [Next] [New Search]